Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  McKesson Corporation    MCK

MCKESSON CORPORATION

(MCK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Summary
  • The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
  • In a short-term perspective, the company has interesting fundamentals.
Strengths
  • The stock, which is currently worth 2021 to 0.11 times its sales, is clearly overvalued in comparison with peers.
  • With a P/E ratio at 13.22 for the current year and 10.76 for next year, earnings multiples are highly attractive compared with competitors.
  • For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
Weaknesses
  • The company has insufficient levels of profitability.
  • The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
Ratings chart
Sector Drug Retailers - NEC
1st jan.Capitalisation (M$)Investor Rating
MCKESSON CORPORATION10.42%24 760
WALGREENS BOOTS ALLIANCE, I..-28.80%36 826
CARDINAL HEALTH, INC.2.41%15 125
WELCIA HOLDINGS CO., LTD.23.88%8 365
SINOPHARM GROUP CO., LTD.-29.70%8 048
DASHENLIN PHARMACEUTICAL GR..72.25%6 966
SHANGHAI PHARMACEUTICALS HO..3.48%6 786
HUADONG MEDICINE CO., LTD4.18%6 290
YIFENG PHARMACY CHAIN CO., ..58.11%6 206
JOINTOWN PHARMACEUTICAL GRO..42.40%5 230
CHINA NATIONAL MEDICINES CO..42.54%4 153
MEDIPAL HOLDINGS CORPORATIO..-16.54%3 933
MATSUMOTOKIYOSHI HOLDINGS C..-9.21%3 671
GALENICA AG14.20%3 568
CLICKS GROUP LIMITED-14.31%3 240
SUZUKEN CO., LTD.-13.44%3 206
More Results
Financials (USD)
Sales 2021 236 B - -
Net income 2021 1 870 M - -
Net Debt 2021 2 045 M - -
P/E ratio 2021 13,2x
Yield 2021 1,12%
Capitalization 24 760 M 24 760 M -
EV / Sales 2020
EV / Sales 2021 0,11x
Nbr of Employees 70 000
Free-Float 59,5%
Upcoming event on MCKESSON CORPORATION
Surperformance© ratings
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
P/E ratio
Potential
Yield
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes